Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
PRUDENTIAL FINANCIAL INC
> AKBA
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | Akebia Therapeutics, Inc. | AKBA | 47,509 | 47,509 | 43,471,000 | 43,471,000 | $915.01 |
06/30/2022 | Akebia Therapeutics, Inc. | AKBA | 0 | -249,912 | 0 | -177,000 | |
03/31/2022 | Akebia Therapeutics, Inc. | AKBA | 249,912 | -381,000 | 177,000 | -1,249,000 | $0.71 |
12/31/2021 | Akebia Therapeutics, Inc. | AKBA | 630,912 | -452,993 | 1,426,000 | -1,695,000 | $2.26 |
09/30/2021 | Akebia Therapeutics, Inc. | AKBA | 1,083,905 | 1,062,864 | 3,121,000 | 3,041,000 | $2.88 |
06/30/2021 | Akebia Therapeutics, Inc. | AKBA | 21,041 | 2,655 | 80,000 | 18,000 | $3.80 |
03/31/2021 | Akebia Therapeutics, Inc. | AKBA | 18,386 | 60 | 62,000 | 11,000 | $3.37 |
12/31/2020 | Akebia Therapeutics, Inc. | AKBA | 18,326 | 0 | 51,000 | 5,000 | $2.78 |
09/30/2020 | Akebia Therapeutics, Inc. | AKBA | 18,326 | 6,659 | 46,000 | -112,000 | $2.51 |
06/30/2020 | Akebia Therapeutics, Inc. | AKBA | 11,667 | 11,667 | 158,000 | 158,000 | $13.54 |
03/31/2020 | Akebia Therapeutics, Inc. | AKBA | 0 | -12,760 | 0 | -81,000 | |
12/31/2019 | Akebia Therapeutics, Inc. | AKBA | 12,760 | 1,600 | 81,000 | 37,000 | $6.35 |
09/30/2019 | Akebia Therapeutics, Inc. | AKBA | 11,160 | 1,143 | 44,000 | -4,000 | $3.94 |
06/30/2019 | Akebia Therapeutics, Inc. | AKBA | 10,017 | -12,540 | 48,000 | -137,000 | $4.79 |
03/31/2019 | Akebia Therapeutics, Inc. | AKBA | 22,557 | -2,476 | 185,000 | 47,000 | $8.20 |
12/31/2018 | Akebia Therapeutics, Inc. | AKBA | 25,033 | 6,673 | 138,000 | -24,000 | $5.51 |
09/30/2018 | Akebia Therapeutics, Inc. | AKBA | 18,360 | -410 | 162,000 | -25,000 | $8.82 |
06/30/2018 | Akebia Therapeutics, Inc. | AKBA | 18,770 | 18,770 | 187,000 | 187,000 | $9.96 |
12/31/2017 | Akebia Therapeutics, Inc. | AKBA | 0 | -49,360 | 0 | -971,000 | |
09/30/2017 | Akebia Therapeutics, Inc. | AKBA | 49,360 | 49,360 | 971,000 | 971,000 | $19.67 |
<< Prev Next >> |
|